Hypertension: Understanding the causes, symptoms, and effective management
Hypertension, commonly known as high blood pressure, is a chronic condition where the force of blood against the artery walls is persistently elevated. While often ... Read More
The surprising link between breastfeeding and maternal heart health
Breastfeeding is widely celebrated for its numerous health benefits for babies, including improved immunity and cognitive development. However, recent research has uncovered an unexpected advantage ... Read More
Unlocking the health benefits of Garlic: Nature’s medicinal marvel
Garlic (Allium sativum), a member of the Liliaceae family, has been valued for centuries as both a culinary delight and a medicinal powerhouse. Known globally ... Read More
Hypertension: Understanding the symptoms, causes, and treatment of high blood pressure
Hypertension, or high blood pressure, is a pervasive medical condition that affects millions worldwide. Often referred to as the "silent killer," it frequently progresses without ... Read More
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More
The Versatile Benefits of Beetroot : From Garden to Table
Beetroot, scientifically known as Beta vulgaris, is a root vegetable known for its deep red color and a multitude of health benefits. Commonly referred to ... Read More
ŌURA introduces new heart health features to enhance user healthspan
ŌURA, renowned for its Oura Ring smart wearable, has announced the introduction of two innovative heart health features, Cardiovascular Age (CVA) and Cardio Capacity, marking ... Read More
Cardurion Pharmaceuticals reveals breakthrough results in heart failure treatment with PDE9 inhibitor
In a significant development for cardiovascular disease treatment, Cardurion Pharmaceuticals, Inc., a clinical-stage biotechnology company, has presented positive results from its Phase 2 proof-of-concept clinical ... Read More
FDA approves expansive label updates for Esperion’s NEXLETOL and NEXLIZET
In a significant advancement for heart health management, Esperion (NASDAQ: ESPR) has announced that the United States Food and Drug Administration (FDA) has approved comprehensive ... Read More
AstraZeneca’s Forxiga wins approval in China for heart failure treatment
AstraZeneca has announced that its drug, Forxiga (dapagliflozin), has received approval from the Chinese National Medical Products Administration (NMPA) to reduce the risk of cardiovascular ... Read More